NGS Homologous Recombinant Deficiency HRR Panel Test sale cost 10530 AED
Genome Signature HRD Test sale cost 54000 AED Genome Signature HRD Test Cost 72,000 د.إ Original price was: 72,000 د.إ.54,000 د.إCurrent price is: 54,000 د.إ.
Bone Marrow Failure Syndrome Test sale cost 7200 AED Bone Marrow Failure Syndrome Test Cost 9,600 د.إ Original price was: 9,600 د.إ.7,200 د.إCurrent price is: 7,200 د.إ.
Sale!

NGS Homologous Recombinant Deficiency HRR Panel Test Cost

Original price was: 11,700 د.إ.Current price is: 10,530 د.إ.

-10%

The NGS Homologous Recombinant Deficiency (HRD) Panel Test is a cutting-edge genetic testing procedure conducted at DNA Labs UAE, designed to assess the efficiency of DNA repair mechanisms in cells, particularly focusing on the homologous recombination repair (HRR) pathway. This test is pivotal in the realm of personalized medicine, especially for patients with cancer, as defects in the HRR pathway are associated with increased sensitivity to certain chemotherapeutic agents and PARP inhibitors.

Utilizing Next-Generation Sequencing (NGS) technology, this panel test comprehensively scans for mutations in genes involved in the HRR pathway, such as BRCA1, BRCA2, and others, which are crucial for accurate DNA repair. Identifying deficiencies in homologous recombination can help predict the response to specific cancer therapies, enabling healthcare providers to tailor treatment plans to the genetic profile of the patient’s tumor, thereby enhancing treatment efficacy and potentially improving patient outcomes.

The test cost is set at 10530 AED, reflecting the sophisticated technology and expertise required to perform this advanced genetic analysis. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, the NGS HRD Panel Test represents a significant advancement in the field of oncology and personalized medicine, offering hope for more effective and customized cancer treatment strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NGS Homologous Recombinant Deficiency HRR Panel Test

Cost: 10530.0 AED

Symptoms, Diagnosis, and Test Details

The NGS Homologous Recombinant Deficiency [HRR] Panel Test is a genetic test that analyzes specific genes involved in repairing DNA damage through a process called homologous recombination. This panel is used to identify mutations or alterations in genes that are associated with an increased risk of cancer, particularly breast and ovarian cancer.

The HRR panel typically includes genes such as BRCA1, BRCA2, PALB2, RAD51C, RAD51D, and ATM, among others. Mutations in these genes can impair the ability of cells to repair DNA damage, leading to an increased risk of cancer.

NGS, or next-generation sequencing, is a technology used to rapidly sequence large amounts of DNA in a single run. This allows for the simultaneous analysis of multiple genes, making it an efficient and cost-effective way to screen for genetic mutations associated with cancer risk.

The NGS HRR panel is typically recommended for individuals with a family history of breast or ovarian cancer, particularly if multiple family members have been diagnosed at a young age. It may also be recommended for individuals with a personal history of breast or ovarian cancer, as well as those with a history of other cancers associated with HRR gene mutations.

Test Information

  • Test Name: NGS Homologous Recombinant Deficiency HRR Panel Test
  • Components: EDTA Vacutainer (2ml)
  • Price: 10530.0 AED
  • Sample Condition: Peripheral blood + FFPE BLOCK
  • Report Delivery: 4-6 weeks
  • Method: NGS
  • Test Type: Genetics
  • Doctor: General Physician
  • Test Department:

Pre Test Information

The NGS Homologous Recombinant Deficiency HRR Panel Test can be done with a doctor’s prescription. However, the prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Conclusion

The results of the NGS HRR panel can help guide personalized cancer risk management strategies, such as increased surveillance or prophylactic surgery, and may also inform treatment decisions for individuals with a cancer diagnosis.

Test Name NGS Homologous Recombinant Deficiency HRR Panel Test
Components EDTA Vacutainer (2ml)
Price 10530.0 AED
Sample Condition Peripheral blood + FFPE BLOCK
Report Delivery 4-6 weeks
Method NGS
Test type Genetics
Doctor General Physician
Test Department:
Pre Test Information NGS Homologous Recombinant Deficiency HRR] Panel can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

The NGS Homologous Recombinant Deficiency [HRR] Panel is a genetic test that analyzes specific genes involved in repairing DNA damage through a process called homologous recombination. This panel is used to identify mutations or alterations in genes that are associated with an increased risk of cancer, particularly breast and ovarian cancer.

The HRR panel typically includes genes such as BRCA1, BRCA2, PALB2, RAD51C, RAD51D, and ATM, among others. Mutations in these genes can impair the ability of cells to repair DNA damage, leading to an increased risk of cancer.

NGS, or next-generation sequencing, is a technology used to rapidly sequence large amounts of DNA in a single run. This allows for the simultaneous analysis of multiple genes, making it an efficient and cost-effective way to screen for genetic mutations associated with cancer risk.

The NGS HRR panel is typically recommended for individuals with a family history of breast or ovarian cancer, particularly if multiple family members have been diagnosed at a young age. It may also be recommended for individuals with a personal history of breast or ovarian cancer, as well as those with a history of other cancers associated with HRR gene mutations.

The results of the NGS HRR panel can help guide personalized cancer risk management strategies, such as increased surveillance or prophylactic surgery, and may also inform treatment decisions for individuals with a cancer diagnosis.

SKU: TEST-699 Category:

Related products